Stockscreener 앱 받기
1.87
4.10%
-0.08
시간 외 거래:
1.89
0.02
+1.07%
Aclaris Therapeutics Inc 주식(ACRS)의 최신 뉴스
Is Aclaris Therapeutics (NASDAQ:ACRS) In A Good Position To Invest In Growth? - Yahoo Finance
Building trade automation scripts for Aclaris Therapeutics Inc.2025 Trade Ideas & Weekly Momentum Picks - newser.com
Full technical analysis of Aclaris Therapeutics Inc. stock2025 Investor Takeaways & Real-Time Sentiment Analysis - newser.com
Real time alert setup for Aclaris Therapeutics Inc. performanceQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - newser.com
Real time breakdown of Aclaris Therapeutics Inc. stock performanceJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Is Aclaris Therapeutics Inc. (8AT) stock testing key supportGDP Growth & Stock Portfolio Risk Control - newser.com
Atopic Dermatitis Pipeline Outlook Report 2025: Insight into emerging drugs, treatment options, clinical trials, and company strategies - The Globe and Mail
What analysts say about Aclaris Therapeutics Inc 8AT stockMarket Sentiment Shifts & Outperform the Market with Aggressive Picks - earlytimes.in
How Aclaris Therapeutics Inc. stock performs during Fed tightening cyclesEarnings Recap Report & Weekly Top Gainers Alerts - newser.com
Sentiment analysis tools applied to Aclaris Therapeutics Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Will Aclaris Therapeutics Inc. rebound enough to break evenRate Cut & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Aclaris Therapeutics Inc.July 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Real time scanner hits for Aclaris Therapeutics Inc. explainedCEO Change & Daily Stock Trend Reports - newser.com
Will Aclaris Therapeutics Inc. (8AT) stock profit from automation waveGold Moves & High Yield Equity Trading Tips - newser.com
Using fundamentals and technicals on Aclaris Therapeutics Inc.Weekly Market Report & High Yield Stock Recommendations - newser.com
Aclaris to Host 2025 R&D Day in New York to Spotlight Immuno-Inflammatory Pipeline - MyChesCo
Using Bollinger Bands to evaluate Aclaris Therapeutics Inc.July 2025 PostEarnings & High Yield Stock Recommendations - newser.com
How high can Aclaris Therapeutics Inc. stock goCPI Data & Free Community Supported Trade Ideas - newser.com
Will Aclaris Therapeutics Inc. (8AT) stock beat revenue estimatesWeekly Trade Review & Accurate Intraday Trade Tips - newser.com
Published on: 2025-10-02 23:56:18 - newser.com
What drives Aclaris Therapeutics Inc stock priceBreakout Stock Watch & Exceptional Return Investment - earlytimes.in
Does Aclaris Therapeutics Inc. qualify in momentum factor screeningWeekly Risk Summary & Precise Buy Zone Tips - newser.com
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025 - Sahm
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, "Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets", in New York on October 14, 2025 - Investing News Network
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, 'Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025 - The Manila Times
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, - GlobeNewswire
Major Immuno-Inflammatory Pipeline Updates: Aclaris R&D Day to Showcase Novel Kinase Inhibitor Progress - Stock Titan
How to read the order book for Aclaris Therapeutics Inc.2025 Sector Review & Community Consensus Trade Alerts - newser.com
5.74%
자본화:
|
볼륨(24시간):